Cleared Traditional

K221323 - Exactech Alteon Short Tapered Wedge

K221323 is the FDA 510(k) clearance for Exactech Alteon Short Tapered Wedge by Exactech, Inc.. It is a Class 2 Orthopedic device (product code LZO) cleared through the Traditional 510(k) pathway after a 378-day FDA review.

K221323 · Exactech, Inc. · Orthopedic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2023
Decision
378d
Days
Class 2
Risk

K221323 is an FDA 510(k) clearance for the Exactech® Alteon® Short Tapered Wedge. Classified as Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented (product code LZO), Class II - Special Controls.

Submitted by Exactech, Inc. (Gainesville, US). The FDA issued a Cleared decision on May 19, 2023 after a review of 378 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3353 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Exactech, Inc. devices

Submission Details

510(k) Number K221323 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 06, 2022
Decision Date May 19, 2023
Days to Decision 378 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
256d slower than avg
Panel avg: 122d · This submission: 378d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3353
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - LZO Prosthesis, Hip, Semi-constrained, Metal/ceramic/polymer, Cemented Or Non-porous, Uncemented

All 419
Devices cleared under the same product code (LZO) and FDA review panel - the closest regulatory comparables to K221323.
MINIMA S System
K231925 · Lima Corporate S.P.A. · Jul 2023
BethaLoc® stem cementless HA
K223103 · Implantcast GmbH · Jun 2023
Xerxes Hip Stem
K231109 · Xerxes Arthopedix, LLC · Jun 2023
BENCOX Delta Option Heads
K223828 · Corentec Co., Ltd. · Mar 2023
ARTICUL/EZE Ceramic Heads
K222296 · Depuy Ireland UC · Jan 2023
U-Motion II Acetabular System-Extension line
K221149 · United Orthopedic Corporation · Jan 2023